ACTSI Investigator Dr. Krishnendu Roy in the News

Krishnendu Roy, PhD, ACTSI investigator, Professor and Wallace H. Coulter Distinguished Faculty Fellow, Carol Ann and David D. Flanagan Professor, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University and Director, Immunoengineering Research Center

Recipient of the Children’s Center for Immunology and Vaccines and Center for Pediatric Nanomedicine 2014 Emory+Children’s Pediatric Research Center Pilot for A Vaccine for Human Rhinoviruses

Health Sciences Update | Georgia ImmunoEngineering Consortium aims to improve/modulate immune response
February 17, 2014

Immunoengineering & Converging Science by Dr. Roy

10 out of 15 Atlanta Business Chronicle Top Medical Researchers from Emory & Georgia Tech are ACTSI Investigators, including Dr. Roy

Publications:
Biomaterials | The Effect of Combined IL10 siRNA and CpG ODN as Pathogen-mimicking Microparticles on Th1/Th2 Cytokine Balance in Dendritic Cells and Protective Immunity against B cell Lymphoma
July 2014

Acta Biometerialia | Engineering vaccines and niches for immune modulation
April 2014

Nature | Cancer vaccines: Material breach
December 18, 2013

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?